Quality of Life After Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Dec 11

PMID 36497314

Authors

Samuel Oxley

Ran Xiong

Xia Wei

Ashwin Kalra

Michail Sideris

Rosa Legood

Ranjit Manchanda

Affiliations

Soon will be listed here.

Abstract

Background: Risk-reducing hysterectomy (RRH) is the gold-standard prevention for endometrial cancer (EC). Knowledge of the impact on quality-of-life (QoL) is crucial for decision-making. This systematic review aims to summarise the evidence.

Methods: We searched major databases until July 2022 (CRD42022347631). Given the paucity of data on RRH, we also included hysterectomy as treatment for benign disease. We used validated quality-assessment tools, and performed qualitative synthesis of QoL outcomes.

Results: Four studies (64 patients) reported on RRH, 25 studies (1268 patients) on hysterectomy as treatment for uterine bleeding. There was moderate risk-of-bias in many studies. Following RRH, three qualitative studies found substantially lowered cancer-worry, with no decision-regret. Oophorectomy (for ovarian cancer prevention) severely impaired menopause-specific QoL and sexual-function, particularly without hormone-replacement. Quantitative studies supported these results, finding low distress and generally high satisfaction. Hysterectomy as treatment of bleeding improved QoL, resulted in high satisfaction, and no change or improvements in sexual and urinary function, although small numbers reported worsening.

Conclusions: There is very limited evidence on QoL after RRH. Whilst there are benefits, most adverse consequences arise from oophorectomy. Benign hysterectomy allows for some limited comparison; however, more research is needed for outcomes in the population of women at increased EC-risk.

References

Kalamo M, Maenpaa J, Seppala T, Mecklin J, Huhtala H, Sorvettula K . Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study. Fam Cancer. 2020; 19(2):177-182. PMC: 7101284. DOI: 10.1007/s10689-020-00158-5. View

Sculpher M, Dwyer N, Byford S, Stirrat G . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol. 1996; 103(2):142-9. DOI: 10.1111/j.1471-0528.1996.tb09666.x. View

Bofill Rodriguez M, Lethaby A, Fergusson R . Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2021; 2:CD000329. PMC: 8095059. DOI: 10.1002/14651858.CD000329.pub4. View

Clarke-Pearson D, Geller E . Complications of hysterectomy. Obstet Gynecol. 2013; 121(3):654-673. DOI: 10.1097/AOG.0b013e3182841594. View

Fergusson R, Bofill Rodriguez M, Lethaby A, Farquhar C . Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019; 8:CD000329. PMC: 6713886. DOI: 10.1002/14651858.CD000329.pub3. View

Wright J, Silver E, Tan S, Hur C, Kastrinos F . Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome. JAMA Netw Open. 2021; 4(9):e2123616. PMC: 8430458. DOI: 10.1001/jamanetworkopen.2021.23616. View

Fortner R, Husing A, Kuhn T, Konar M, Overvad K, Tjonneland A . Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort. Int J Cancer. 2016; 140(6):1317-1323. DOI: 10.1002/ijc.30560. View

Saed L, Varse F, Baradaran H, Moradi Y, Khateri S, Friberg E . The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis. BMC Cancer. 2019; 19(1):527. PMC: 6544993. DOI: 10.1186/s12885-019-5748-4. View

Gaba F, Manchanda R . Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers. Best Pract Res Clin Obstet Gynaecol. 2020; 65:46-65. DOI: 10.1016/j.bpobgyn.2020.01.006. View

10.

. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Aberdeen Endometrial Ablation Trials Group. Br J Obstet Gynaecol. 1999; 106(4):360-6. DOI: 10.1111/j.1471-0528.1999.tb08275.x. View

11.

Lee A, Mavaddat N, Wilcox A, Cunningham A, Carver T, Hartley S . BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019; 21(8):1708-1718. PMC: 6687499. DOI: 10.1038/s41436-018-0406-9. View

12.

Weissman A, Hartz A, Hansen M, Johnson S . The natural history of primary dysmenorrhoea: a longitudinal study. BJOG. 2004; 111(4):345-52. DOI: 10.1111/j.1471-0528.2004.00090.x. View

13.

Altman D, Granath F, Cnattingius S, Falconer C . Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study. Lancet. 2007; 370(9597):1494-9. DOI: 10.1016/S0140-6736(07)61635-3. View

14.

Lawlor D, Adamson J, Ebrahim S . Lay perceptions of a 'natural' menopause. Cross sectional study of the British Women's Heart and Health Study. BJOG. 2002; 109(12):1398-400. DOI: 10.1046/j.1471-0528.2002.02046.x. View

15.

Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivela A . Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet. 2001; 357(9252):273-7. DOI: 10.1016/S0140-6736(00)03615-1. View

16.

Jain P, Rajaram S, Gupta B, Goel N, Srivastava H . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. Int J Gynaecol Obstet. 2016; 135(2):140-144. DOI: 10.1016/j.ijgo.2016.04.020. View

17.

Bafligil C, Thompson D, Lophatananon A, Smith M, Ryan N, Naqvi A . Association between genetic polymorphisms and endometrial cancer risk: a systematic review. J Med Genet. 2020; 57(9):591-600. PMC: 7476276. DOI: 10.1136/jmedgenet-2019-106529. View

18.

Karimi M, Brazier J . Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. Pharmacoeconomics. 2016; 34(7):645-9. DOI: 10.1007/s40273-016-0389-9. View

19.

Moldovan R, Keating S, Clancy T . The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Fam Cancer. 2014; 14(1):51-60. DOI: 10.1007/s10689-014-9761-0. View

20.

Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A . Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2009; 127(2):442-51. DOI: 10.1002/ijc.25050. View